Adenovirus type 5 encodes a 14.7-kDa protein that protects infected cells from tumor necrosis factor-induced cytolysis by an unknown mechanism. In this report, we demonstrate that infection of cells with an adenovirus vector expressing Fas ligand induced rapid apoptosis that was blocked by coinfection with a virus expressing 14.7K. Moreover, AdFasL/G infection resulted in the rapid activation of DEVD-specific caspases, and caspase activation was blocked by coinfection with Ad14.7/G. Cell death induced by the overexpression of Fas ligand, Fas-associated death domain-containing protein (FADD)/MORT1, or FADD-like interleukin-1␤-converting enzyme (FLICE)/caspase-8 in a virus-free system was efficiently blocked by 14.7K expression. Moreover, we demonstrate that 14.7K interacts with FLICE. These results support the idea that FLICE is a cellular target for the 14.7-kDa protein.
Apoptosis, or programmed cell death, is a physiological process that is required for the normal development and homeostasis of multicellular organisms and involves the destruction of cells that are no longer required or are potentially dangerous (1) . The elimination of virus-infected cells by apoptosis is an efficient means of limiting virus production and resolving viral infections (2) . This can be triggered by cytotoxic T lymphocytes (3) or by cytokines such as TNF 1 and interleukin-1␤ that are released following viral infection (4) . However, viruses have evolved sophisticated mechanisms to counter this host defense. (5) (6) (7) .
After ligand binding, Fas (CD-95/APO-1) and TNFR1 induce apoptosis by recruiting the cytosolic adapter protein FADD, also called MORT1, to the activated receptor (8) . The TNFR1 does this indirectly through the adapter protein TRADD (9) . The signaling complex arranged at these death receptors includes FLICE, also called MACH, Mch5, and caspase-8, a caspase that contains an N-terminal DED (10, 11) . FADD recruits FLICE to the receptor complex through interactions with their respective DEDs. Activation of FLICE occurs at this receptor complex, and it is thought that activated FLICE then cleaves and activates downstream DEVD-specific caspases that are involved in executing the death signal (10 -13) .
The adenovirus type 5 14.7-kDa protein is a highly conserved product of the E3 transcription unit (14) . 14.7K functions to inhibit the death of susceptible cells after exposure to TNF (15, 16) . Treatment of cells with TNF induces the activation of cPLA 2 , and in at least some cell types, cPLA 2 appears to be required for TNF-induced cytotoxicity (17) . The finding that 14.7K blocked arachidonic acid release after TNF treatment (18 -20) suggested that it may function by inhibiting the activation or activity of cPLA 2 . However, the role of the 14.7-kDa protein in the Fas signaling pathway has not been examined, and its precise mechanism of action has remained elusive.
EXPERIMENTAL PROCEDURES
Materials-The anti-Flag M2 monoclonal antibody was purchased from Eastman Kodak Co. (Rochester, NY). The anti-poly(ADP-ribose) polymerase monoclonal antibody was purchased from Upstate Biotechnology Inc. (Lake Placid, NY). The FasL-specific antibody was purchased from Transduction Labs (Lexington, KY). The YAMA-specific antibody was purchased from Santa Cruz (Santa Cruz, CA). The antimouse and anti-rabbit IgG conjugated to horseradish peroxidase were purchased from Boehringer Mannheim. Ac-DEVD-␣-(4-methyl-coumaryl-7-amide) and AMC were obtained from Peptides International, Inc. (Louisville, KY). The enhanced chemiluminescence Western blot analysis reagents and Promix 35 S label were purchased from Amersham Life Sciences, Inc. Ni 2ϩ ⅐nitrilotriacetic acid-agarose resin and the bacterial expression vector pQE32 were purchased from Qiagen Inc. (Chatsworth, CA). The pcDNA expression vectors for FLICE, FADD, and YAMA were generously provided by Vishva M. Dixit, and the cDNA for CrmA was kindly provided by David Pickup.
Plasmid Construction-pMT3tagS was constructed by inserting the adapter, R1stopSALs AATTTAGCCCGCC, R1stopSALa TCGAG-GCGGGCTA between the EcoRI and SalI sites of pMT3 tag (21) . pMT3-14.7HA was constructed by polymerase chain reaction amplification of the Ad5 14.7K gene using oligos A5s30453 (Bam/Pst) CGGGATCCTG-CAGCCACCATGACTGACACCCTAGATCTAGAATG and A5a30836 (Pst) AACTGCAGCGTTAAAGGGAATAAGATCTTTG. The 14.7K polymerase chain reaction product was digested with BamHI and PstI and inserted into the BamHI and PstI sites of pMT3tagS. pMT3F is similar to pMT3tagS, except that it contains the Flag tag in place of the HA tag. pMT3-14.7F expresses a C-terminal Flag-tagged 14.7-kDa protein from the pMT3F vector. pAd14.7K/G and pAdFasL/G are duel expression vectors that drive Ad5 14.7K or the murine FasL, respectively, from the CMV promoter and the ␤-glucuronidase gene from the Rous sarcoma virus promoter. pAdCrmA and pAdGFP express CrmA or GFP respectively from the CMV promoter in the Ad5 shuttle vector. pQE32-14.7K was constructed by polymerase chain reaction amplification of the 14.7K gene, encoding amino acids 1-128 using oligos A5s30453(Bam) CGGGATCCTGATGACTGACAC-CCTAGATCTAGAAATG and A5a30839(Pst) AACTGCAGTTAGTTA-AAGGGAATAAGATCTTTG, followed by cloning into the BamHI and PstI sites of pQE32.
Cells and Virus-A549 cells, a human lung carcinoma cell line, and 293 cells, a human embryonic kidney cell line transformed by sheared Ad5 DNA, were obtained from American Type Culture Collection and were maintained in Dulbecco's modified Eagle's medium supplemented with 10% calf serum. AdFasL/G, Ad14.7/G, AdNull/G, and AdCrmA express their respective transgenes from the cytomegalovirus promoter inserted at the site of the E1 deletion. All adenovirus vectors were generated using the pAdFasL/G, pAd14.7/G, pAdNull/G, and pAdCrmA * The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
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14.7K Antibody Production-The 14.7-kDa protein was purified by Ni 2ϩ ⅐nitrilotriacetic acid chromatography according to the manufacturer's suggestions. Briefly, 20 ml of a stationary phase culture of Escherichia coli, DH5␣FЈIQ cells transformed with the pQE32-14.7K expression plasmid were added to 1 liter of superbroth containing 100 g/ml ampicillin. The cells were grown at 37°C until the absorbance at 600 nm reached 0.6. Isopropyl-␤-D-thiogalactopyranoside was added to a final concentration of 1 mM, the temperature was reduced to 28°C, and the cells were incubated with good aeration for an additional 20 h. The cells were harvested by centrifugation at 4,000 ϫ g for 10 min at 4°C, and the pellet was resuspended in buffer A (6 M guanidine hydrochloride, 0.1 M sodium phosphate, 0.01 M Tris (pH 8)) at 4 ml/gm wet weight and stirred at room temperature for 1 h. The lysate was centrifuged at 10,000 ϫ g for 20 min. The supernatant was incubated with 8 ml of a 50% slurry of Ni 2ϩ ⅐nitrilotriacetic acid-agarose resin (previously equilibrated in buffer A) at room temperature for 45 min and loaded onto a 1.6-cm diameter column. The column was washed with 10 column volumes of buffer A and 5 column volumes of buffer B (8 M urea, 0.1 M sodium phosphate, 0.01 M Tris (pH 8)) and then washed with buffer C (8 M urea, 0.1 M sodium phosphate, 0.01 M Tris (pH 8)) until the optical density at 280 nm reached Ͻ0.01. The His-tagged 14.7-kDa protein was eluted with buffer C containing 250 mM imidazole. The Bradford assay and SDS-polyacrylamide gel electrophoresis were used to locate the peak fractions. The peak fractions were pooled and renatured by dialysis for 6 h against buffer D containing 2 M urea and 1 M NaCl, followed by dialysis against buffer D (250 mM NaCl, 2 mM MgCl 2 , 0.1% Nonidet P-40, 25 mM Tris (pH 8)) for 12 h. The solution was centrifuged at 10,000 ϫ g to remove insoluble materials, and the protein concentration was determined by the Bradford assay. The 14.7-kDa-specific antiserum was obtained from rabbits immunized with His-14.7-kDa protein that was generated by electrophoreses of the renatured, partially purified protein on a preparative, 15% SDS-polyacrylamide gel stained with Coomassie Blue.
AMC Assay-293 cells were infected with viruses at a multiplicity of infection of 5 plaque-forming units/cell. At 4 h post-infection, cells were lysed in a buffer containing 1% Triton X-100, 50 mM Tris (pH 8) and 150 mM NaCl. Aliquots (300 g) of cell lysate were incubated with the Ac-DEVD-␣(4-methyl-coumaryl-7-amide) fluorogenic substrate for the indicated time periods (min), and AMC release was measured by spectrofluorometry. AMC concentration was determined from a standard curve.
Coimmunoprecipitation Assay-293 cells were cotransfected by calcium phosphate precipitation with expression vectors encoding 14.7F (10 g), HA-tagged FLICE (5 g) or control vectors along with a CrmA expression vector (5 g) to ensure that apoptosis induced by the overexpression of FLICE was efficiently blocked. 12-16 h after transfection, cells were labeled with 200 Ci/ml Promix 35 S label (Amersham Corp.) for 2-4 h at 37°C. Labeled cells were washed and lysed in 1 ml of ice-cold Nonidet P-40 lysis buffer (20 mM Tris (pH 8), 137 mM NaCl, 10% glycerol, 1% Nonidet P-40) containing 1 mM phenylmethylsulfonyl fluoride, 5 g/ml aprotinin, 5 g/ml leupeptin. Immunoprecipitated products were analyzed by SDS-polyacrylamide gel electrophoresis followed by fluorography.
RESULTS

14.7K Blocks Apoptosis and DEVD-specific Caspase Activity
Induced by FasL-To determine whether 14.7K blocks apoptosis induced by Fas oligomerization, we used an adenovirus vector that expresses FasL to induce apoptosis in 293 cells. FasL expression was detectable at 3 h post-infection and increased significantly at 4 h post-infection with AdFasL/G but not with a control virus (Fig. 1A) . Cell surface-associated FasL was rapidly proteolytically cleaved, liberating soluble FasL and leaving behind the intracellular domain anchored to the membrane. The time course of FasL expression correlated well with apoptosis induction as evidenced by poly(ADP-ribose) polymerase cleavage (Fig. 1B) , morphology, and the induction of DEVDspecific caspase activity (data not shown). Elevation in YVADspecific caspase activity was not observed between 1 and 5 h post-infection (data not shown). Coinfection with virus that expressed either 14.7K or CrmA efficiently blocked Fas ligandtriggered apoptosis (Fig. 1C) and prevented the induction of DEVD-specific caspase activity (Fig. 1D) . These results suggest that 14.7K functions to impede FasL-induced apoptosis by blocking the activation or the activity of one or several caspases.
14.7K Blocks Cell Death Induced by the Overexpression of FasL, FADD, or FLICE-To confirm the results obtained with the adenovirus constructs in a virus-free system and to further explore the mechanism of 14.7K activity, the ability of 14.7K to block apoptosis induced by overexpressing FasL, FADD, or FLICE was assessed. 293 cells were transiently transfected with plasmids that express GFP and either FasL, FADD, or FLICE together with either 14.7K or CrmA. In this assay, GFP was used to tag transfected cells. Like CrmA, 14.7K expression efficiently protected cells from apoptosis induced by overexpression of each of these death inducing proteins (Fig. 2) . Inhibition of cell death by the 14.7K product was not cell typespecific, as we observed similar effects in A549 cells (Fig. 2D ). This analysis indicated that 14.7K interferes with FasL-induced apoptosis at the level of or downstream of FLICE and that 14.7K function does not require any additional adenovirus products. Since 14.7K blocked the generation of DEVD-specific caspase activity induced by FasL expression (Fig. 1D) and FLICE can directly activate DEVD-specific caspases (13, 24, 25) , these results suggest that FLICE or DEVD-specific caspases such as YAMA/CPP32/caspase-3 may be cellular targets for 14.7K.
14.7K Interacts with FLICE-To directly test whether 14.7K interacts with FLICE in vivo, 293 cells were transiently transfected with plasmids that direct the synthesis of Flag epitopetagged 14.7K (14.7F) and HA epitope-tagged FLICE. The 14.7K-or Flag-specific antibodies coprecipitated a 55-kDa protein that corresponds to FLICE and a 26-kDa protein from 35 S-labeled cell lysates (Fig. 3) . Control antibodies did not coprecipitate FLICE or the 26-kDa protein nor were they efficiently coprecipitated from lysates that contained FLICE but not 14.7F (Fig. 3) . It is likely that the 26-kDa product corresponds to the N-terminal-processed DED of FLICE, since the molecular mass of this proteolytic fragment was reported to be 26 kDa (12) .
The in vivo association between 14.7K and FLICE was confirmed by Western analysis. 293 cells were transiently transfected with plasmids that direct the synthesis of 14.7F and either FLICE-HA or YAMA. Immunoprecipitation of FLICE-HA from cell lysates with the HA-specific antibody coprecipitated 14.7F. Immunoprecipitation of YAMA with a YAMA-specific antibody did not coprecipitate 14.7F. Conversely, immunoprecipitation of 14.7F coprecipitated FLICE-HA but not YAMA (data not shown). These results revealed a physical interaction between 14.7K and FLICE. DISCUSSION FLICE is the first caspase to be activated during apoptosis induced by Fas and TNFR1 oligomerization. FLICE becomes processed and activated within the death receptor signaling complex, possibly by an autocatalytic mechanism involving FLICE oligomerization (12, 13) . After activation, FLICE is thought to trigger a caspase cascade that involves the activation of downstream DEVD-specific caspases (13, 25, 27) .
Interruption protease appears to be an effective point of intervention for DNA viruses. Recently, Muzio et al. (13) demonstrated that CrmA formed a complex with and inhibited the activity of FLICE. In addition, several anti-apoptotic DED-containing viral products, termed vFLIPs, have recently been identified by data base searches (5-7). These vFLIPs include the molluscum contagiosum virus proteins MC159 and MC160 and the equine herpes virus 2 protein E8. MC159 was shown to bind to FADD and inhibit apoptosis induced by TNFR1 and Fas (5-7). E8 interacted with FLICE (5, 7) and inhibited apoptosis induced by the overexpression of Fas, TRADD and FADD but not by FLICE (5) . On the other hand, 14.7K lacks a discernible DED, interacted with FLICE, and attenuated FLICE-induced apoptosis. This suggests that the mechanism of action of 14.7K may be different from that of the vFLIPs. Since FLICE is a shared effector caspase for both TNFR1 and Fas, it is likely that 14.7K interferes with TNF-induced apoptosis through its interaction with FLICE and through its inhibition of DEVD-specific caspase activity. However, previous studies have suggested that 14.7K may inhibit TNF-induced apoptosis by blocking the activation or activity of cPLA 2 (18 -20) . The role of 14.7K in apoptosis appears to be further clarified by the recent finding that TNF-induced apoptosis and arachidonic acid release can occur by a mechanism involving the activation of cPLA 2 by caspase cleavage (28) . This finding suggests that attenuation of DEVD-specific caspase activation by 14.7K may prevent the subsequent activation of cPLA 2 and thus inhibit arachidonic acid release and apoptosis.
The ability of 14.7K to protect cells from TNF and FasLinduced apoptosis may be involved in the establishment and maintenance of latent or persistent adenovirus infections in lymphocytes. During lytic infection, the protective effect of the 14.7K protein might be essential for optimal viral replication. Considering the lack of persistence of adenoviruses used for gene therapy applications (26) and the functional exclusion of 14.7K from these vectors, the expression of 14.7K in future adenovirus constructs may be beneficial in a clinical setting. S]methionine, and the cell lysates were divided and used for immunoprecipitations (IP) with either the 14.7K-specific antiserum, the prebleed, the Flag M2 monoclonal antibody, or the isotype control as indicated. The immunoprecipitated products were resolved by SDSpolyacrylamide gel electrophoresis, and the dried gels were subjected to fluorography. The positions of the molecular mass markers (in kilodaltons) are shown.
